调节性T细胞清除改变肿瘤微环境并加速胰腺癌发生
该研究在小鼠胰腺癌模型中清除调节性T细胞(Treg),意外发现Treg清除未能缓解免疫抑制,反而加速肿瘤进展。机制上,Treg是TGFβ配体的重要来源,其清除重编程成纤维细胞群体,导致表达平滑肌肌动蛋白的肿瘤限制性成纤维细胞丢失,同时趋化因子Ccl3、Ccl6、Ccl8增加,招募髓系细胞并恢复免疫抑制。阻断CCR1可抑制该效应。
要点
- Treg清除在胰腺癌中不缓解免疫抑制,反而加速肿瘤进展。
- Treg通过TGFβ维持肿瘤限制性成纤维细胞,清除后成纤维细胞重编程。
- CCR1阻断可抑制Treg清除引起的髓系细胞招募和免疫抑制恢复。
核心结论
- Treg清除在胰腺癌小鼠模型中加速肿瘤进展,而非缓解免疫抑制。
- Treg是TGFβ配体的关键来源,其清除导致成纤维细胞群体重编程。
- CCR1阻断可抑制Treg清除后髓系细胞招募和免疫抑制恢复。
研究设计与样本
- 在小鼠胰腺癌模型中清除Treg,观察肿瘤进展和微环境变化。
主要发现
- Treg清除后肿瘤进展加速,免疫抑制未缓解。
- Treg清除导致表达平滑肌肌动蛋白的肿瘤限制性成纤维细胞丢失。
- Treg清除后趋化因子Ccl3、Ccl6、Ccl8增加,髓系细胞招募增加。
- Treg清除引发病理性CD4+ T细胞反应。
- 阻断CCR1可抑制Treg清除后的髓系细胞招募和肿瘤促进作用。
临床怎么用
- 胰腺癌中靶向Treg需谨慎,可能加速肿瘤进展。
- CCR1阻断可能是缓解胰腺癌免疫抑制的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Regulatory T cells (Treg) are abundant in human and mouse pancreatic cancer. To understand the contribution to the immunosuppressive microenvironment, we depleted Tregs in a mouse model of pancreatic cancer. Contrary to our expectations, Treg depletion failed to relieve immunosuppression and led to accelerated tumor progression. We show that Tregs are a key source of TGFβ ligands and, accordingly, their depletion reprogramed the fibroblast population, with loss of tumor-restraining, smooth muscle actin-expressing fibroblasts. Conversely, we observed an increase in chemokines Ccl3, Ccl6, and Ccl8 leading to increased myeloid cell recruitment, restoration of immune suppression, and promotion of carcinogenesis, an effect that was inhibited by blockade of the common CCL3/6/8 receptor CCR1. Further, Treg depletion unleashed pathologic CD4+ T-cell responses. Our data point to new mechanisms regulating fibroblast differentiation in pancreatic cancer and support the notion that fibroblasts are a heterogeneous population with different and opposing functions in pancreatic carcinogenesis. SIGNIFICANCE: Here, we describe an unexpected cross-talk between Tregs and fibroblasts in pancreatic cancer. Treg depletion resulted in differentiation of inflammatory fibroblast subsets, in turn driving infiltration of myeloid cells through CCR1, thus uncovering a potentially new therapeutic approach to relieve immunosuppression in pancreatic cancer.See related commentary by Aykut et al., p. 345.This article is highlighted in the In This Issue feature, p. 327.
引用
- Zhang Y, Lazarus J, Steele NG, et al. Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis. Cancer Discov. 2020. PMID: 31911451. doi:10.1158/2159-8290.CD-19-0958
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。